Volume | 201,427 |
|
|||||
News | - | ||||||
Day High | 1.45 | Low High |
|||||
Day Low | 1.29 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.44 | 1.29 | 1.45 | 1.34 | 1.37 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,042 | 201,427 | $ 1.38 | $ 278,726 | - | 0.650101 - 2.12 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:25:40 | formt | 179 | $ 1.34 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
98.63M | 74.72M | - | 8.23M | -32.49M | -0.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.18 | 1.48 | 1.10 | 1.33 | 283,983 | 0.16 | 13.56% |
1 Month | 1.72 | 1.76 | 1.10 | 1.37 | 319,102 | -0.38 | -22.09% |
3 Months | 1.35 | 2.12 | 1.10 | 1.55 | 386,771 | -0.01 | -0.74% |
6 Months | 0.71 | 2.12 | 0.650101 | 1.39 | 284,644 | 0.63 | 88.73% |
1 Year | 1.06 | 2.12 | 0.650101 | 1.30 | 197,822 | 0.28 | 26.42% |
3 Years | 2.97 | 7.73 | 0.650101 | 3.42 | 559,911 | -1.63 | -54.88% |
5 Years | 1.30 | 7.73 | 0.56 | 2.83 | 585,120 | 0.04 | 3.08% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |